Literature DB >> 10890993

Benign cutaneous vascular tumors of infancy: when to worry, what to do.

D W Metry1, A A Hebert.   

Abstract

OBJECTIVES: To discuss the current knowledge regarding complicated hemangiomas (cervicofacial, periorbital, lumbosacral, and parotid), including the associated syndromes of diffuse neonatal hemangiomatosis and PHACES (posterior fossa malformations, most commonly of the Dandy-Walker variant; hemangiomas [especially large, plaquelike, facial lesions]; arterial anomalies; cardiac anomalies and coarctation of the aorta; eye abnormalities; and sternal cleft and/or supraumbilical raphe). To discuss 2 newly recognized entities that may be a source of diagnostic confusion with the common hemangioma, the kaposiform hemangioendothelioma and tufted angioma. To discuss the risks and benefits of current treatment options, including the use of systemic corticosteroids and interferon in necessary situations. DATA SOURCES: The pertinent world literature was reviewed and incorporated into experience from our pediatric dermatology practice at the University of Texas Medical School at Houston.
CONCLUSIONS: The common hemangioma, kaposiform hemangioendothelioma, and tufted angioma, though benign histologically, may cause serious consequences for children. Dermatologists should be able to recognize unique clinical presentations of these lesions and obtain further diagnostic evaluation accordingly. Dermatologists should also be aware of available treatment options, including the use of systemic chemotherapy in life-threatening situations.

Entities:  

Mesh:

Year:  2000        PMID: 10890993     DOI: 10.1001/archderm.136.7.905

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

Review 1.  MR imaging of soft tissue tumors and tumor-like lesions.

Authors:  Tal Laor
Journal:  Pediatr Radiol       Date:  2003-12-12

2.  Hypothesis: the metastatic niche theory can elucidate infantile hemangioma development.

Authors:  Martin C Mihm; J Stuart Nelson
Journal:  J Cutan Pathol       Date:  2010-04       Impact factor: 1.587

3.  Beta-blockers as therapy for infantile hemangiomas.

Authors:  Harrison P Nguyen; Brent B Pickrell; Teresa S Wright
Journal:  Semin Plast Surg       Date:  2014-05       Impact factor: 2.314

4.  Conservative management of ulcerated haemangioma--twenty years experience.

Authors:  Anand Pandey; Ajay Narayan Gangopadhyay; Shiv Prasad Sharma; Vijayendra Kumar; Saroj Chooramani Gopal; Dinesh Kumar Gupta
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

Review 5.  Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.

Authors:  T Muir; M Kirsten; P Fourie; N Dippenaar; G O Ionescu
Journal:  Pediatr Surg Int       Date:  2004-01-22       Impact factor: 1.827

6.  Impact of congenital cutaneous hemangiomas on newborn care in the United States.

Authors:  Raghav Tripathi; Rishabh S Mazmudar; Konrad D Knusel; Harib H Ezaldein; Leah T Belazarian; Jeremy S Bordeaux; Jeffrey F Scott
Journal:  Arch Dermatol Res       Date:  2020-10-19       Impact factor: 3.017

7.  Hemangiomas in children: challenges and outcome of surgical management in benin city, Nigeria.

Authors:  Osarumwense David Osifo; Iyekoretin Evbuomwan
Journal:  Iran J Pediatr       Date:  2011-09       Impact factor: 0.364

8.  Surgical management of vascular anomalies in children at a tertiary care hospital in a resource-limited setting: a Tanzanian experience with 134 patients.

Authors:  Phillipo L Chalya; Neema M Kayange; Peter F Rambau; Mange Manyama; Japhet M Gilyoma
Journal:  BMC Res Notes       Date:  2015-11-30

9.  Masterly inactivity in infantile haemangioma: Does it still hold relevance?

Authors:  Nitin Sharma; Minu Bajpai; Ajay Verma; Shasanka Shekhar Panda; Amit K Singh
Journal:  Afr J Paediatr Surg       Date:  2015 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.